HISTOGENICS CORP's ticker is HSGX and the CUSIP is 43358V109. A total of 21 filers reported holding HISTOGENICS CORP in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $656,000 | -88.1% | 1,203,399 | -45.4% | 0.02% | -87.5% |
| Q2 2018 | $5,508,000 | -9.1% | 2,203,277 | 0.0% | 0.14% | -15.3% |
| Q1 2018 | $6,059,000 | +66.3% | 2,203,277 | +23.9% | 0.17% | +40.5% |
| Q4 2017 | $3,644,000 | -48.2% | 1,777,777 | -50.0% | 0.12% | -9.7% |
| Q3 2017 | $7,038,000 | +121.2% | 3,555,554 | +100.0% | 0.13% | -16.2% |
| Q2 2017 | $3,182,000 | +3.5% | 1,777,777 | 0.0% | 0.16% | -8.6% |
| Q1 2017 | $3,075,000 | +3.6% | 1,777,777 | 0.0% | 0.18% | -17.1% |
| Q4 2016 | $2,968,000 | -48.0% | 1,777,777 | 0.0% | 0.21% | -42.7% |
| Q3 2016 | $5,706,000 | – | 1,777,777 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| S Squared Technology, LLC | 1,149,387 | $3,161,000 | 2.71% |
| Abingworth LLP | 888,889 | $2,444,000 | 1.52% |
| Sofinnova Investments, Inc. | 2,077,040 | $5,712,000 | 0.98% |
| Third Security, LLC | 2,690,570 | $7,399,000 | 0.54% |
| Perceptive Advisors | 2,203,277 | $6,059,000 | 0.17% |
| Archon Capital Management LLC | 232,318 | $639,000 | 0.06% |
| Palo Alto Investors LP | 302,922 | $833,000 | 0.04% |
| Rossmore Private Capital | 11,236 | $31,000 | 0.03% |
| BRADLEY FOSTER & SARGENT INC/CT | 72,200 | $199,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 150,000 | $413,000 | 0.00% |